Quarterly report pursuant to Section 13 or 15(d)

Accrued expenses and Other Liabilities (Tables)

v3.21.2
Accrued expenses and Other Liabilities (Tables)
9 Months Ended
Sep. 30, 2021
Accrued Expenses and Other Liabilities  
Schedule of accrued expenses and other liabilities

Accrued expenses and other liabilities consist of the following:

September 30, 

December 31, 

    

2021

    

2020

Accrued preclinical and clinical trial expenses

$

529,482

$

628,000

Accrued manufacturing expenses

174,174

175,089

Compensation and related benefits

458,914

209,600

Accrued franchise tax

 

147,500

 

172,500

Other expenses

 

350,218

 

429,345

$

1,660,288

$

1,614,534